| # | Country | Total Patents | |
|---|---|---|---|
| #1 | WIPO (World Intellectual Property Organization) | 7 | |
| #2 | Australia | 3 | |
| #3 | Brazil | 1 | |
| #4 | EPO (European Patent Office) | 1 | |
| #5 | Norway | 1 |
| # | Industry | |
|---|---|---|
| #1 | Biotechnology | |
| #2 | Pharmaceuticals | |
| #3 | Medical technology | |
| #4 | Computer technology | |
| #5 | Measurement |
| # | Technology | |
|---|---|---|
| #1 | Microorganisms | |
| #2 | Medical preparations | |
| #3 | Peptides | |
| #4 | Syringes | |
| #5 | Healthcare informatics | |
| #6 | Therapeutic chemical compounds | |
| #7 | Analysing materials |
| # | Name | Total Patents |
|---|---|---|
| #1 | Gruenberg Micheal L | 6 |
| #2 | Chavan Surendra | 6 |
| #3 | Gruenberg Michael L | 3 |
| #4 | Thatte Jayant | 2 |
| #5 | El-Kalay Mohammad A | 2 |
| #6 | Chitnis Vivek | 2 |
| #7 | Chavan Surendra Jagannath | 1 |
| #8 | Chavan Surendra J | 1 |
| #9 | Gruenberg Micheal | 1 |
| Publication | Filing date | Title |
|---|---|---|
| WO2005049085A1 | Use of soluble complexes to facilitate cell activation | |
| WO2005007116A2 | Artificial antigen presenting cell devices | |
| WO2004087876A2 | Use of red blood cells to facilitate cell activation | |
| AU2003272598A1 | Th1 cell adoptive immunotherapy | |
| AU2003272582A1 | Re-activated t-cells for adoptive immunotherapy | |
| WO03024312A2 | Cell therapy system | |
| EP1480519A1 | Re-activated t-cells for adoptive immunotherapy | |
| WO03043643A1 | Closed sterile system devices and methods |